Furthermore, the analysis of ARCN1 expression in human tumors shows that higher levels of ARCN1 expression correlates with lower survival rate of gastric, ovarian, and HER+ positive breast cancer patients (Fig. 4d). The gene discussed is ARCN1; the disease is breast carcinoma.